Recent developments and highlights in biomarkers in allergic diseases and asthma
The potential of precision medicine in allergy and asthma has only started to be explored. A significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food allergy and drug hypersensitivity was made in the last decade. This improved understanding led to a better c...
Saved in:
| Published in | Allergy (Copenhagen) Vol. 73; no. 12; pp. 2290 - 2305 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Denmark
Blackwell Publishing Ltd
01.12.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0105-4538 1398-9995 1398-9995 |
| DOI | 10.1111/all.13628 |
Cover
| Abstract | The potential of precision medicine in allergy and asthma has only started to be explored. A significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food allergy and drug hypersensitivity was made in the last decade. This improved understanding led to a better classification of the distinct phenotypes and to the discovery of new drugs such as biologicals, targeting phenotype‐specific mechanisms. Nevertheless, many conditions remain poorly understood such as non‐eosinophilic airway diseases or non‐IgE–mediated food allergy. Moreover, there is a need to predict the response to specific therapies and the outcome of drug and food provocations. The identification of patients at risk of progression towards severity is also an unmet need in order to establish adequate preventive or therapeutic measures. The implementation of precision medicine in the clinical practice requires the identification of phenotype‐specific markers measurable in biological matrices. To become useful, these biomarkers need to be quantifiable by reliable systems, and in samples obtained in an easy, rapid and cost‐efficient way. In the last years, significant research resources have been put in the identification of valid biomarkers for asthma and allergic diseases. This review summarizes these recent advances with focus on the biomarkers with higher clinical applicability. |
|---|---|
| AbstractList | The potential of precision medicine in allergy and asthma has only started to be explored. A significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food allergy and drug hypersensitivity was made in the last decade. This improved understanding led to a better classification of the distinct phenotypes and to the discovery of new drugs such as biologicals, targeting phenotype-specific mechanisms. Nevertheless, many conditions remain poorly understood such as non-eosinophilic airway diseases or non-IgE-mediated food allergy. Moreover, there is a need to predict the response to specific therapies and the outcome of drug and food provocations. The identification of patients at risk of progression towards severity is also an unmet need in order to establish adequate preventive or therapeutic measures. The implementation of precision medicine in the clinical practice requires the identification of phenotype-specific markers measurable in biological matrices. To become useful, these biomarkers need to be quantifiable by reliable systems, and in samples obtained in an easy, rapid and cost-efficient way. In the last years, significant research resources have been put in the identification of valid biomarkers for asthma and allergic diseases. This review summarizes these recent advances with focus on the biomarkers with higher clinical applicability.The potential of precision medicine in allergy and asthma has only started to be explored. A significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food allergy and drug hypersensitivity was made in the last decade. This improved understanding led to a better classification of the distinct phenotypes and to the discovery of new drugs such as biologicals, targeting phenotype-specific mechanisms. Nevertheless, many conditions remain poorly understood such as non-eosinophilic airway diseases or non-IgE-mediated food allergy. Moreover, there is a need to predict the response to specific therapies and the outcome of drug and food provocations. The identification of patients at risk of progression towards severity is also an unmet need in order to establish adequate preventive or therapeutic measures. The implementation of precision medicine in the clinical practice requires the identification of phenotype-specific markers measurable in biological matrices. To become useful, these biomarkers need to be quantifiable by reliable systems, and in samples obtained in an easy, rapid and cost-efficient way. In the last years, significant research resources have been put in the identification of valid biomarkers for asthma and allergic diseases. This review summarizes these recent advances with focus on the biomarkers with higher clinical applicability. The potential of precision medicine in allergy and asthma has only started to be explored. A significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food allergy and drug hypersensitivity was made in the last decade. This improved understanding led to a better classification of the distinct phenotypes and to the discovery of new drugs such as biologicals, targeting phenotype‐specific mechanisms. Nevertheless, many conditions remain poorly understood such as non‐eosinophilic airway diseases or non‐IgE–mediated food allergy. Moreover, there is a need to predict the response to specific therapies and the outcome of drug and food provocations. The identification of patients at risk of progression towards severity is also an unmet need in order to establish adequate preventive or therapeutic measures. The implementation of precision medicine in the clinical practice requires the identification of phenotype‐specific markers measurable in biological matrices. To become useful, these biomarkers need to be quantifiable by reliable systems, and in samples obtained in an easy, rapid and cost‐efficient way. In the last years, significant research resources have been put in the identification of valid biomarkers for asthma and allergic diseases. This review summarizes these recent advances with focus on the biomarkers with higher clinical applicability. |
| Author | Barber, Domingo Hew, Mark Eguiluz‐Gracia, Ibon Escribese, Maria M. Torres, Maria J. Tay, Tunn Ren O'Hehir, Robyn E. |
| Author_xml | – sequence: 1 givenname: Ibon surname: Eguiluz‐Gracia fullname: Eguiluz‐Gracia, Ibon organization: ARADyAL – sequence: 2 givenname: Tunn Ren orcidid: 0000-0001-5729-647X surname: Tay fullname: Tay, Tunn Ren organization: Changi General Hospital – sequence: 3 givenname: Mark orcidid: 0000-0002-7498-0000 surname: Hew fullname: Hew, Mark organization: Monash University – sequence: 4 givenname: Maria M. surname: Escribese fullname: Escribese, Maria M. organization: Universidad San Pablo CEU – sequence: 5 givenname: Domingo orcidid: 0000-0002-5488-5700 surname: Barber fullname: Barber, Domingo organization: Universidad San Pablo CEU – sequence: 6 givenname: Robyn E. surname: O'Hehir fullname: O'Hehir, Robyn E. organization: Monash University – sequence: 7 givenname: Maria J. surname: Torres fullname: Torres, Maria J. email: mjtorresj@gmail.com organization: Andalusian Center for Nanomedicine and Biotechnology ‐ BIONAND |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30289997$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1LAzEQhoNU7Ice_AOy4EUP2ya7yW5yLMUvKCii5yWbTNvU7G5Ntkr_vbGtHgoaGJKB5528M9NHnbqpAaFzgocknJG0dkjSLOFHqEdSwWMhBOugHiaYxZSlvIv63i8xxnki8Anqpjjhgcl76OkZFNRtpOEDbLOqwttHstbRwswXNkRITR2VpqmkewO3zcJ_4OZGRdp4kB52CunbRSVP0fFMWg9n-3uAXm9vXib38fTx7mEynsaKMspjpqjOWBlMzwTTKmegebBHU8g5zpkCRgjmCeZEJ1QyIWSmBSV4ltKy1JKnA3S1q7tyzfsafFtUxiuwVtbQrH2REJJxKrggAb08QJfN2tXBXaAyglOSsCxQF3tqXVagi5UzoeVN8TOrAFzvAOUa7x3MfhGCi-89FGEuxXYPgR0dsMq0sjVN3Tpp7H-KT2Nh83fpYjyd7hRfp0-W_w |
| CitedBy_id | crossref_primary_10_1111_all_14282 crossref_primary_10_31665_JFB_2020_10228 crossref_primary_10_1111_all_14044 crossref_primary_10_1111_pai_13189 crossref_primary_10_1080_21645515_2019_1622976 crossref_primary_10_1177_01455613211050698 crossref_primary_10_1111_all_14565 crossref_primary_10_1111_all_15258 crossref_primary_10_1111_all_15412 crossref_primary_10_1186_s12890_023_02383_x crossref_primary_10_1002_clt2_12229 crossref_primary_10_3389_fmed_2023_1187557 crossref_primary_10_1111_all_14206 crossref_primary_10_1111_all_14645 crossref_primary_10_1111_all_14764 crossref_primary_10_1111_all_14969 crossref_primary_10_1038_s41598_023_47915_x crossref_primary_10_1186_s40733_018_0047_4 crossref_primary_10_2174_1381612829666230828104015 crossref_primary_10_1111_all_14607 crossref_primary_10_1080_1744666X_2023_2200936 crossref_primary_10_3389_fimmu_2021_691964 crossref_primary_10_2500_aap_2021_42_200100 crossref_primary_10_3390_app13031273 crossref_primary_10_7717_peerj_13247 crossref_primary_10_3390_jcm9123827 crossref_primary_10_15690_pf_v16i5_2058 crossref_primary_10_3389_fphar_2020_594427 crossref_primary_10_1111_all_14579 crossref_primary_10_1002_ctd2_11 crossref_primary_10_4081_mrm_2020_656 crossref_primary_10_1111_all_13728 crossref_primary_10_1016_j_jff_2023_105418 crossref_primary_10_4103_lungindia_lungindia_129_21 crossref_primary_10_3390_ijms25063501 crossref_primary_10_1016_j_jaip_2021_08_017 crossref_primary_10_1080_02770903_2019_1604743 crossref_primary_10_1111_all_14061 crossref_primary_10_1111_all_14582 crossref_primary_10_1111_all_14586 crossref_primary_10_1111_all_13851 crossref_primary_10_1111_all_13973 crossref_primary_10_3390_metabo12070592 crossref_primary_10_1002_jcp_28718 crossref_primary_10_1007_s12016_020_08830_5 crossref_primary_10_1016_j_jaip_2022_10_027 crossref_primary_10_1016_j_jaip_2020_02_036 crossref_primary_10_1111_all_13811 crossref_primary_10_1111_all_13856 crossref_primary_10_1007_s40521_021_00281_3 crossref_primary_10_1016_j_compbiomed_2023_107544 crossref_primary_10_1016_j_genrep_2025_102179 crossref_primary_10_1016_j_waojou_2023_100787 crossref_primary_10_3390_jcm8071062 crossref_primary_10_1016_j_scitotenv_2024_174924 crossref_primary_10_1016_j_rmed_2025_107940 crossref_primary_10_1038_s41467_024_54684_2 crossref_primary_10_1111_all_14032 crossref_primary_10_1111_pai_13474 crossref_primary_10_4062_biomolther_2024_177 crossref_primary_10_1111_all_14078 crossref_primary_10_3389_fimmu_2022_1094172 crossref_primary_10_1038_s41598_022_18443_x crossref_primary_10_1111_all_15889 crossref_primary_10_1002_hsr2_70191 crossref_primary_10_1111_all_13824 crossref_primary_10_3389_fnut_2025_1519271 crossref_primary_10_56871_CmN_W_2024_26_19_014 crossref_primary_10_1111_all_16418 crossref_primary_10_3390_foods10112662 crossref_primary_10_1111_all_13749 crossref_primary_10_47026_2413_4864_2021_3_60_68 crossref_primary_10_1007_s11882_020_00920_w crossref_primary_10_33549_physiolres_934398 crossref_primary_10_3390_jcm12165404 crossref_primary_10_1186_s12890_022_02020_z crossref_primary_10_3389_falgy_2021_747591 |
| Cites_doi | 10.1111/all.12206 10.1016/j.jaci.2014.05.038 10.1080/03007995.2017.1347091 10.3109/01902148.2011.649823 10.1111/all.13117 10.1016/j.jaci.2009.02.012 10.1111/all.12820 10.1111/cea.12147 10.1016/j.jaci.2013.10.011 10.1111/all.13176 10.1111/ped.13305 10.1111/pai.12535 10.1111/cea.12797 10.1016/j.jaci.2016.07.030 10.1111/all.13181 10.1016/j.jaci.2015.09.001 10.1111/cea.13057 10.1111/all.13124 10.1038/srep36599 10.1111/all.13147 10.1111/all.13496 10.1164/rccm.201208-1414OC 10.1126/scitranslmed.aab3142 10.1016/j.jaci.2016.11.041 10.1016/j.anai.2017.01.018 10.1002/ppul.23331 10.1016/j.rmed.2015.09.016 10.1111/all.13235 10.1016/j.jaci.2013.12.1091 10.1016/j.jaci.2016.09.028 10.1111/cea.12434 10.1111/cea.13192 10.1183/13993003.00336-2016 10.1111/all.13205 10.1111/all.12889 10.1183/13993003.01817-2017 10.1183/13993003.02298-2016 10.1002/mnfr.201700669 10.1183/13993003.00324-2018 10.18176/jiaci.0264 10.1016/j.clim.2017.09.008 10.1111/all.13046 10.1186/s12967-017-1365-7 10.1056/NEJMoa1804092 10.1111/all.12817 10.1038/clpt.2011.355 10.1038/nm.2678 10.18632/oncotarget.13374 10.1183/09031936.05.00029705 10.1111/all.12785 10.1016/j.jaci.2016.12.963 10.1002/ppul.23371 10.1111/all.13138 10.1164/rccm.200701-085OC 10.1002/alr.21598 10.1111/j.1398-9995.2008.01713.x 10.1111/all.13340 10.1038/s41598-017-12261-2 10.1111/all.13399 10.1136/thx.2010.135574 10.1056/NEJMoa0706135 10.1164/rccm.201709-1948OC 10.1183/13993003.02383-2016 10.1016/j.jaci.2013.03.044 10.1007/s11882-018-0767-9 10.1016/j.rmed.2007.01.011 10.1016/j.jaci.2013.08.026 10.1111/cea.12794 10.1016/j.jaci.2016.09.031 10.1016/j.jaci.2016.05.041 10.1111/all.13049 10.1016/j.anai.2018.04.020 10.1111/cea.12179 10.1183/13993003.02523-2017 10.1016/j.chest.2016.10.008 10.1186/s12890-016-0230-4 10.1016/j.jaci.2017.03.028 10.1016/j.jaci.2009.11.032 10.1111/cea.12145 10.1111/all.12644 10.1016/j.jaci.2016.08.032 10.1111/all.13121 10.1016/S2213-2600(16)30031-5 10.1016/j.jaci.2012.11.017 10.1016/S2213-2600(15)00367-7 10.1016/S0140-6736(02)11679-5 10.1183/13993003.02536-2017 10.1111/pai.12510 10.1038/nri.2016.111 10.1136/thx.2008.103069 10.1111/j.1365-2222.2004.02110.x 10.1016/j.jaci.2013.03.003 10.1136/thoraxjnl-2014-205634 10.1111/all.13136 10.1111/all.13236 10.1016/j.jaci.2015.05.041 10.1111/cea.12735 10.1038/s41598-017-09120-5 10.1111/all.13596 10.1016/j.jaci.2017.01.022 10.1111/all.12922 10.1111/all.13075 10.1111/apa.13550 10.1111/cea.12965 10.1016/j.jaci.2016.02.018 10.1016/S2213-2600(17)30424-1 10.1111/all.13132 10.1111/all.13211 10.1111/cea.12901 10.1016/j.anai.2013.08.012 10.1038/clpt.2013.103 10.1016/j.jaip.2017.01.026 10.1111/all.12886 10.1111/pai.12726 10.1001/jamaoto.2016.0927 10.1111/all.13143 10.1080/02770903.2018.1455855 10.1097/01.mlg.0000147917.43615.c0 10.1164/rccm.201604-0866OC 10.1016/j.jaci.2013.04.050 10.1016/j.jaci.2015.12.1324 10.1016/j.jaci.2015.09.058 10.1111/all.13254 10.1016/j.jaci.2015.07.037 10.1097/MD.0000000000003679 10.1111/cea.13165 10.1111/all.13439 10.1111/pai.12457 10.1164/rccm.201504-0760OC 10.1016/j.jaci.2015.05.037 10.1111/resp.12602 10.1067/mai.2001.118891 10.1164/rccm.200905-0695OC 10.2500/aap.2016.37.3899 10.1016/j.jaci.2014.10.026 10.1016/j.jaip.2016.11.004 10.1183/09031936.00024313 10.1053/j.gastro.2017.05.066 10.1016/j.alit.2016.04.011 10.1001/jamadermatol.2013.4114 10.1002/iid3.161 10.1016/j.jaci.2015.05.022 10.1016/j.prostaglandins.2015.07.001 10.1016/S2213-2600(15)00050-8 10.1111/cea.12902 10.1016/j.ijporl.2015.12.001 10.1183/13993003.00800-2017 10.1111/all.12573 10.1111/all.13302 10.1056/NEJMcibr1514013 10.1111/all.13563 10.1111/all.12142 10.1111/j.1398-9995.2006.01268.x 10.1002/lary.26555 10.1111/cea.12975 10.1056/NEJMoa0808991 10.1159/000448755 10.1111/pai.12827 10.1097/MPG.0000000000001553 10.1111/all.13350 10.1111/all.12891 10.2174/1381612822666160928142814 10.1016/j.jaip.2016.03.004 10.1183/13993003.02135-2016 |
| ContentType | Journal Article |
| Copyright | 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Copyright © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
| Copyright_xml | – notice: 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. – notice: Copyright © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
| DBID | AAYXX CITATION NPM 7T5 H94 K9. 7X8 |
| DOI | 10.1111/all.13628 |
| DatabaseName | CrossRef PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef PubMed AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1398-9995 |
| EndPage | 2305 |
| ExternalDocumentID | 30289997 10_1111_all_13628 ALL13628 |
| Genre | reviewArticle Journal Article Review |
| GrantInformation_xml | – fundername: Institute of Health “Carlos III” of the Spanish Ministry of Economy and Competitiveness – fundername: European Regional Development Fund (ERDF) funderid: RD16/0006/0001; RD16/0006/0015; PI15/02256; PI16/00249; PI17/01318 – fundername: Rio Hortega funderid: CM17/00140 – fundername: Regional Ministry of Health of Andalusia funderid: PI‐0346‐2016; PC‐0278‐2017 – fundername: European Social Fund – fundername: Regional Ministry of Health of Andalusia grantid: PC-0278-2017 – fundername: European Regional Development Fund (ERDF) grantid: PI16/00249 – fundername: Rio Hortega grantid: CM17/00140 – fundername: European Regional Development Fund (ERDF) grantid: PI17/01318 – fundername: European Regional Development Fund (ERDF) grantid: RD16/0006/0001 – fundername: European Regional Development Fund (ERDF) grantid: PI15/02256 – fundername: Regional Ministry of Health of Andalusia grantid: PI-0346-2016 – fundername: Institute of Health "Carlos III" of the Spanish Ministry of Economy and Competitiveness – fundername: European Regional Development Fund (ERDF) grantid: RD16/0006/0015 |
| GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY NPM 7T5 H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c4548-5c4d65b362f95dc75ed800743e78075ce511082081d24a599a6d9410f34bbda83 |
| IEDL.DBID | DR2 |
| ISSN | 0105-4538 1398-9995 |
| IngestDate | Fri Jul 11 02:27:40 EDT 2025 Fri Jul 25 09:26:22 EDT 2025 Mon Jul 21 05:55:19 EDT 2025 Thu Apr 24 23:11:51 EDT 2025 Tue Jul 01 05:15:57 EDT 2025 Wed Jan 22 16:37:56 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | chronic rhinosinusitis asthma drug hypersensitivity food allergy biomarkers |
| Language | English |
| License | 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4548-5c4d65b362f95dc75ed800743e78075ce511082081d24a599a6d9410f34bbda83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-5488-5700 0000-0002-7498-0000 0000-0001-5729-647X |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.13628 |
| PMID | 30289997 |
| PQID | 2161031256 |
| PQPubID | 34098 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_2116849891 proquest_journals_2161031256 pubmed_primary_30289997 crossref_primary_10_1111_all_13628 crossref_citationtrail_10_1111_all_13628 wiley_primary_10_1111_all_13628_ALL13628 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2018 |
| PublicationDateYYYYMMDD | 2018-12-01 |
| PublicationDate_xml | – month: 12 year: 2018 text: December 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | Denmark |
| PublicationPlace_xml | – name: Denmark – name: Zurich |
| PublicationTitle | Allergy (Copenhagen) |
| PublicationTitleAlternate | Allergy |
| PublicationYear | 2018 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | 2017; 5 2017; 7 2007; 101 2017; 8 2018; 121 2017; 47 2015; 70 2013; 68 2017; 49 2017; 151 2012; 18 2017; 195 2016; 71 2015; 109 2016; 105 2010; 181 2005; 26 2001; 108 2014; 133 2016; 37 2016; 142 2018; 48 2014; 134 2017; 118 2017; 72 2015; 45 2018; 6 2015; 135 2015; 136 2007; 176 2017; 33 2013; 94 2004; 34 2018; 378 2013; 111 2009; 123 2008; 358 2018; 73 2009; 360 2016; 81 2007; 62 2016; 193 2012; 67 2016; 48 2017; 127 2016; 46 2018; 29 2018; 28 2015; 5 2009; 64 2015; 3 2013; 43 2017; 28 2010; 125 2013; 149 2017; 65 2015; 121 2016; 51 2016; 95 2018; 62 2012; 38 2013; 187 2016; 16 2015; 7 2014; 44 2017; 139 2014; 43 2018; 197 2016; 4 2017; 50 2015; 26 2018; 18 2016; 6 2018; 154 2012; 91 2004; 114 2017; 15 2017; 59 2002; 360 2015; 20 2016; 65 2018 2017; 183 2016; 374 2017; 140 2016; 138 2018; 51 2016; 137 2013; 132 2016; 170 2016; 27 2016; 9 2016; 22 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_40_1 e_1_2_10_109_1 e_1_2_10_131_1 e_1_2_10_158_1 e_1_2_10_70_1 e_1_2_10_93_1 e_1_2_10_2_1 e_1_2_10_139_1 e_1_2_10_18_1 e_1_2_10_74_1 e_1_2_10_97_1 e_1_2_10_116_1 e_1_2_10_150_1 e_1_2_10_6_1 e_1_2_10_55_1 e_1_2_10_135_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_78_1 e_1_2_10_112_1 e_1_2_10_154_1 e_1_2_10_13_1 e_1_2_10_32_1 e_1_2_10_51_1 e_1_2_10_120_1 e_1_2_10_166_1 e_1_2_10_147_1 e_1_2_10_82_1 e_1_2_10_128_1 e_1_2_10_29_1 e_1_2_10_63_1 e_1_2_10_86_1 e_1_2_10_105_1 e_1_2_10_124_1 e_1_2_10_162_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_67_1 e_1_2_10_101_1 e_1_2_10_143_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_41_1 e_1_2_10_132_1 e_1_2_10_155_1 e_1_2_10_159_1 e_1_2_10_90_1 e_1_2_10_71_1 e_1_2_10_117_1 e_1_2_10_94_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_75_1 e_1_2_10_113_1 e_1_2_10_136_1 e_1_2_10_151_1 e_1_2_10_38_1 e_1_2_10_98_1 e_1_2_10_56_1 e_1_2_10_79_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_121_1 e_1_2_10_144_1 e_1_2_10_148_1 e_1_2_10_60_1 e_1_2_10_106_1 e_1_2_10_129_1 e_1_2_10_83_1 e_1_2_10_64_1 e_1_2_10_102_1 e_1_2_10_125_1 e_1_2_10_140_1 e_1_2_10_163_1 e_1_2_10_49_1 e_1_2_10_87_1 e_1_2_10_26_1 e_1_2_10_68_1 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_69_1 e_1_2_10_42_1 e_1_2_10_156_1 e_1_2_10_91_1 e_1_2_10_72_1 e_1_2_10_95_1 e_1_2_10_118_1 e_1_2_10_4_1 e_1_2_10_53_1 e_1_2_10_137_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_76_1 e_1_2_10_99_1 e_1_2_10_114_1 e_1_2_10_152_1 e_1_2_10_8_1 e_1_2_10_57_1 e_1_2_10_133_1 e_1_2_10_58_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_30_1 e_1_2_10_119_1 Petsky HL (e_1_2_10_110_1) 2016; 9 e_1_2_10_145_1 e_1_2_10_80_1 e_1_2_10_149_1 e_1_2_10_61_1 e_1_2_10_84_1 e_1_2_10_107_1 e_1_2_10_126_1 e_1_2_10_160_1 e_1_2_10_27_1 e_1_2_10_65_1 e_1_2_10_88_1 e_1_2_10_103_1 e_1_2_10_141_1 e_1_2_10_122_1 e_1_2_10_164_1 e_1_2_10_24_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_108_1 e_1_2_10_130_1 e_1_2_10_157_1 e_1_2_10_92_1 e_1_2_10_73_1 e_1_2_10_115_1 e_1_2_10_138_1 e_1_2_10_96_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_77_1 e_1_2_10_111_1 e_1_2_10_134_1 e_1_2_10_153_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_59_1 e_1_2_10_31_1 e_1_2_10_50_1 e_1_2_10_146_1 e_1_2_10_81_1 e_1_2_10_62_1 e_1_2_10_104_1 e_1_2_10_127_1 e_1_2_10_161_1 e_1_2_10_85_1 e_1_2_10_28_1 e_1_2_10_66_1 e_1_2_10_100_1 e_1_2_10_123_1 e_1_2_10_142_1 e_1_2_10_165_1 e_1_2_10_47_1 e_1_2_10_89_1 |
| References_xml | – volume: 7 start-page: 10116 year: 2017 article-title: Increased expression of Siglec‐9 in chronic obstructive pulmonary disease publication-title: Sci Rep – volume: 43 start-page: 421 year: 2014 end-page: 429 article-title: Differences in plasma and sputum biomarkers between COPD and COPD‐asthma overlap publication-title: Eur Respir J – volume: 20 start-page: 1282 year: 2015 end-page: 1284 article-title: Adjusting prednisone using blood eosinophils reduces exacerbations and improves asthma control in difficult patients with asthma publication-title: Respirology – volume: 5 start-page: 894 year: 2015 end-page: 899 article-title: Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis publication-title: Int Forum Allergy Rhinol – volume: 70 start-page: 474 year: 2015 end-page: 494 article-title: Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report publication-title: Allergy – volume: 6 start-page: 29 year: 2018 end-page: 39 article-title: Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non‐specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial publication-title: Lancet Respir Med – volume: 181 start-page: 1033 year: 2010 end-page: 1041 article-title: Use of exhaled nitric oxide measurement to identify a reactive, at‐risk phenotype among patients with asthma publication-title: Am J Respir Crit Care Med – year: 2018 article-title: Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well‐controlled asthmatics publication-title: J Asthma – volume: 9 start-page: Cd011440 year: 2016 article-title: Exhaled nitric oxide levels to guide treatment for adults with asthma publication-title: Cochrane Database Syst Rev – volume: 94 start-page: 324 year: 2013 end-page: 328 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for HLA‐B genotype and carbamazepine dosing publication-title: Clin Pharmacol Ther – year: 2018 article-title: Precision medicine in united airways disease: a “treatable traits” approach publication-title: Allergy – volume: 378 start-page: 2486 year: 2018 end-page: 2496 article-title: Dupilumab efficacy and safety in moderate‐to‐severe uncontrolled asthma publication-title: N Engl J Med – volume: 16 start-page: 751 year: 2016 end-page: 765 article-title: Food allergy: immune mechanisms, diagnosis and immunotherapy publication-title: Nat Rev Immunol – volume: 72 start-page: 1133 year: 2017 end-page: 1147 article-title: Allergen immunotherapy for IgE‐mediated food allergy: a systematic review and meta‐analysis publication-title: Allergy – volume: 132 start-page: 235 year: 2013 end-page: 237 article-title: False‐positive penicillin immunoassay: an unnoticed common problem publication-title: J Allergy Clin Immunol – volume: 46 start-page: 1111 year: 2016 end-page: 1119 article-title: Nonsteroidal anti‐inflammatory drugs enhance IgE‐mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti‐inflammatory drugs publication-title: Clin Exp Allergy – volume: 5 start-page: 1335 year: 2017 end-page: 1343 article-title: Asthma control and sputum eosinophils: a longitudinal study in daily practice publication-title: J Allergy Clin Immunol Pract – volume: 51 start-page: 582 year: 2016 end-page: 587 article-title: MicroRNA expression profiling in children with different asthma phenotypes publication-title: Pediatr Pulmonol – volume: 132 start-page: 305 year: 2013 end-page: 312 article-title: Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids publication-title: J Allergy Clin Immunol – volume: 47 start-page: 113 year: 2017 end-page: 120 article-title: sIgE Ana o 1, 2 and 3 accurately distinguish tolerant from allergic children sensitized to cashew nuts publication-title: Clin Exp Allergy – year: 2018 article-title: Local allergic rhinitis: implications for management publication-title: Clin Exp Allergy – volume: 101 start-page: 1483 year: 2007 end-page: 1492 article-title: Predicting and evaluating response to omalizumab in patients with severe allergic asthma publication-title: Respir Med – volume: 123 start-page: 1103 year: 2009 end-page: 1110 article-title: Evaluation of serum s‐IgE/total IgE ratio in predicting clinical response to allergen‐specific immunotherapy publication-title: J Allergy Clin Immunol – volume: 132 start-page: 72 year: 2013 end-page: 80 article-title: Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects publication-title: J Allergy Clin Immunol – volume: 26 start-page: 523 year: 2005 end-page: 548 article-title: Exhaled breath condensate: methodological recommendations and unresolved questions publication-title: Eur Respir J – volume: 136 start-page: 571 issue: 3 year: 2015 end-page: 580 article-title: Metabolomic profiling of asthma and chronic obstructive pulmonary disease: a pilot study differentiating diseases publication-title: J Allergy Clin Immunol – volume: 72 start-page: 1801 year: 2017 end-page: 1805 article-title: Serum levels of 9alpha,11beta‐PGF2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis publication-title: Allergy – volume: 51 start-page: 1702536 year: 2018 article-title: Associations between blood eosinophils and decline in lung function among adults with and without asthma publication-title: Eur Respir J – volume: 71 start-page: 556 year: 2016 end-page: 562 article-title: Cor a 14 is the superior serological marker for hazelnut allergy in children, independent of concomitant peanut allergy publication-title: Allergy – volume: 81 start-page: 15 year: 2016 end-page: 20 article-title: Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy publication-title: Int J Pediatr Otorhinolaryngol – volume: 16 start-page: 67 year: 2016 article-title: Periostin levels and eosinophilic inflammation in poorly‐controlled asthma publication-title: BMC Pulm Med – year: 2018 article-title: Exhaled breath condensate volatilome allows sensitive diagnosis of persistent asthma publication-title: Allergy – volume: 140 start-page: 720 year: 2017 end-page: 729 article-title: Microparticles in nasal lavage fluids in chronic rhinosinusitis: potential biomarkers for diagnosis of aspirin‐exacerbated respiratory disease publication-title: J Allergy Clin Immunol – volume: 51 start-page: 1702523 year: 2018 article-title: Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study publication-title: Eur Respir J – volume: 8 start-page: 7384 year: 2017 end-page: 7390 article-title: High cord blood CCL22/CXCL10 chemokine ratios precede allergic sensitization in early childhood publication-title: Oncotarget – volume: 34 start-page: 1768 year: 2004 end-page: 1775 article-title: The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams publication-title: Clin Exp Allergy – volume: 72 start-page: 1962 year: 2017 end-page: 1971 article-title: Identification of a plasma miRNA biomarker signature for allergic asthma: a translational approach publication-title: Allergy – volume: 137 start-page: 750 year: 2016 end-page: 757 article-title: Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity publication-title: J Allergy Clin Immunol – volume: 197 start-page: 876 year: 2018 end-page: 884 article-title: Sputum eosinophilia and magnetic resonance imaging ventilation heterogeneity in severe asthma publication-title: Am J Respir Crit Care Med – volume: 138 start-page: 1344 year: 2016 end-page: 1353 article-title: Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania publication-title: J Allergy Clin Immunol – volume: 27 start-page: 117 year: 2016 end-page: 125 article-title: Improving the safety of oral immunotherapy for food allergy publication-title: Pediatr Allergy Immunol – volume: 68 start-page: 702 year: 2013 end-page: 712 article-title: Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper publication-title: Allergy – volume: 137 start-page: 1433 year: 2016 end-page: 1446 article-title: Asthma inflammatory phenotypes show differential microRNA expression in sputum publication-title: J Allergy Clin Immunol – volume: 358 start-page: 568 year: 2008 end-page: 579 article-title: HLA‐B*5701 screening for hypersensitivity to abacavir publication-title: N Engl J Med – volume: 49 start-page: 1602383 year: 2017 article-title: Differences between asthma‐COPD overlap syndrome and adult‐onset asthma publication-title: Eur Respir J – volume: 47 start-page: 37 year: 2017 end-page: 47 article-title: Metabolomic analysis identifies potential diagnostic biomarkers for aspirin‐exacerbated respiratory disease publication-title: Clin Exp Allergy – volume: 132 start-page: 328 year: 2013 end-page: 335 article-title: The chitinase‐like protein YKL‐40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma publication-title: J Allergy Clin Immunol – volume: 62 start-page: 1700669 year: 2018 article-title: Immunological changes induced in peach allergy patients with systemic reactions by Pru p 3 sublingual immunotherapy publication-title: Mol Nutr Food Res – volume: 134 start-page: 1175 year: 2014 end-page: 1186 article-title: Increased frequency of dual‐positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma publication-title: J Allergy Clin Immunol – volume: 68 start-page: 1177 year: 2013 end-page: 1184 article-title: Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia publication-title: Allergy – volume: 73 start-page: 490 year: 2018 end-page: 497 article-title: Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma publication-title: Allergy – volume: 65 start-page: 520 year: 2017 end-page: 525 article-title: Using serum IgE antibodies to predict esophageal eosinophilia in children publication-title: J Pediatr Gastroenterol Nutr – volume: 73 start-page: 221 year: 2018 end-page: 229 article-title: Delayed‐type hypersensitivity reactions induced by proton pump inhibitors: a clinical and in vitro T‐cell reactivity study publication-title: Allergy – volume: 114 start-page: 1895 year: 2004 end-page: 1905 article-title: Molecular and cellular staging for the severity of chronic rhinosinusitis publication-title: Laryngoscope – volume: 360 start-page: 1715 issue: 9347 year: 2002 end-page: 1721 article-title: Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial publication-title: Lancet – volume: 140 start-page: 1004 year: 2017 end-page: 1014 article-title: Airway and serum biochemical correlates of refractory neutrophilic asthma publication-title: J Allergy Clin Immunol – volume: 70 start-page: 995 year: 2015 end-page: 1003 article-title: Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study publication-title: Allergy – volume: 133 start-page: 1557 year: 2014 end-page: 1563 article-title: Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis publication-title: J Allergy Clin Immunol – volume: 51 start-page: 316 year: 2016 end-page: 328 article-title: A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma publication-title: Pediatr Pulmonol – volume: 140 start-page: 1043 year: 2017 end-page: 1053 article-title: Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy publication-title: J Allergy Clin Immunol – volume: 72 start-page: 985 year: 2017 end-page: 993 article-title: Programmed cell death‐1 expression correlates with disease severity and IL‐5 in chronic rhinosinusitis with nasal polyps publication-title: Allergy – volume: 138 start-page: 1608 year: 2016 end-page: 1618 article-title: Individualized therapy for persistent asthma in young children publication-title: J Allergy Clin Immunol – volume: 91 start-page: 734 year: 2012 end-page: 738 article-title: Clinical pharmacogenetics implementation consortium guidelines for HLA‐B genotype and abacavir dosing publication-title: Clin Pharmacol Ther – volume: 73 start-page: 1609 year: 2018 end-page: 1621 article-title: Diagnostic accuracy, risk assessment, and cost‐effectiveness of component‐resolved diagnostics for food allergy: a systematic review publication-title: Allergy – volume: 139 start-page: 1687 year: 2017 end-page: 1688 article-title: Longitudinal variation of serum periostin levels in adults with stable asthma publication-title: J Allergy Clin Immunol – volume: 142 start-page: 731 year: 2016 end-page: 737 article-title: Mucous cytokine levels in chronic rhinosinusitis‐associated olfactory loss publication-title: JAMA Otolaryngol Head Neck Surg – volume: 108 start-page: S147 issue: 5 Suppl year: 2001 end-page: S334 article-title: Allergic rhinitis and its impact on asthma publication-title: J Allergy Clin Immunol – volume: 360 start-page: 973 year: 2009 end-page: 984 article-title: Mepolizumab and exacerbations of refractory eosinophilic asthma publication-title: N Engl J Med – volume: 183 start-page: 293 year: 2017 end-page: 299 article-title: Increased innate type 2 immune response in house dust mite‐allergic patients with allergic rhinitis publication-title: Clin Immunol – volume: 118 start-page: 290 year: 2017 end-page: 297 article-title: Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure publication-title: Ann Allergy Asthma Immunol – volume: 170 start-page: 201 year: 2016 end-page: 205 article-title: Increased CD69 expression on peripheral eosinophils from patients with food protein‐induced enterocolitis syndrome publication-title: Int Arch Allergy Immunol – volume: 105 start-page: 1349 year: 2016 end-page: 1354 article-title: Changes in biomarkers during a six‐month oral immunotherapy intervention for cow's milk allergy publication-title: Acta Paediatr – volume: 48 start-page: 93 year: 2018 end-page: 95 article-title: Blood eosinophils: the forgotten man of inhaled steroid dose titration publication-title: Clin Exp Allergy – volume: 49 start-page: 1602135 year: 2017 article-title: T‐helper cell type 2 (Th2) and non‐Th2 molecular phenotypes of asthma using sputum transcriptomics in U‐BIOPRED publication-title: Eur Respir J – volume: 151 start-page: 262 year: 2017 end-page: 277 article-title: Asthma metabolomics and the potential for integrative omics in research and the clinic publication-title: Chest – volume: 72 start-page: 616 year: 2017 end-page: 626 article-title: Identification of phenotypic clusters of nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease publication-title: Allergy – volume: 47 start-page: 1159 year: 2017 end-page: 1169 article-title: Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma publication-title: Clin Exp Allergy – volume: 18 start-page: 716 year: 2012 end-page: 725 article-title: Asthma phenotypes: the evolution from clinical to molecular approaches publication-title: Nat Med – volume: 72 start-page: 1006 year: 2017 end-page: 1021 article-title: Precision medicine in allergic disease‐food allergy, drug allergy, and anaphylaxis‐PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology publication-title: Allergy – volume: 193 start-page: 131 year: 2016 end-page: 142 article-title: Increased YKL‐40 and chitotriosidase in asthma and chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 73 start-page: 905 year: 2018 end-page: 915 article-title: Specific immunotherapy in local allergic rhinitis: a randomized, double‐blind placebo‐controlled trial with Phleum pratense subcutaneous allergen immunotherapy publication-title: Allergy – volume: 72 start-page: 2039 year: 2017 end-page: 2043 article-title: Immediate moxifloxacin hypersensitivity: is there more than currently meets the eye? publication-title: Allergy – volume: 64 start-page: 374 year: 2009 end-page: 380 article-title: Heterogeneity of asthma according to blood inflammatory patterns publication-title: Thorax – volume: 111 start-page: 423 year: 2013 end-page: 425 article-title: Are skin tests useful in fluoroquinolone hypersensitivity diagnosis? publication-title: Ann Allergy Asthma Immunol – volume: 65 start-page: 243 year: 2016 end-page: 252 article-title: Endotypes of allergic diseases and asthma: an important step in building blocks for the future of precision medicine publication-title: Allergol Int – volume: 26 start-page: 772 year: 2015 end-page: 779 article-title: Predicting asthma morbidity in children using proposed markers of Th2‐type inflammation publication-title: Pediatr Allergy Immunol – volume: 4 start-page: 549 year: 2016 end-page: 556 article-title: Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies publication-title: Lancet Respir Med – volume: 72 start-page: 453 year: 2017 end-page: 461 article-title: A new framework for the documentation and interpretation of oral food challenges in population‐based and clinical research publication-title: Allergy – volume: 29 start-page: 42 year: 2018 end-page: 49 article-title: Sputum TWEAK expression correlates with severity and degree of control in non‐eosinophilic childhood asthma publication-title: Pediatr Allergy Immunol – volume: 121 start-page: 163 issue: Pt B year: 2015 end-page: 169 article-title: Aspirin provocation increases 8‐iso‐PGE2 in exhaled breath condensate of aspirin‐hypersensitive asthmatics publication-title: Prostaglandins Other Lipid Mediat – volume: 67 start-page: 199 year: 2012 end-page: 208 article-title: A systematic review and meta‐analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) publication-title: Thorax – volume: 154 start-page: 346 year: 2018 end-page: 359 article-title: Diagnosis and treatment of eosinophilic esophagitis publication-title: Gastroenterology – year: 2018 article-title: Multi‐omics analysis points to altered platelet functions in severe food‐associated respiratory allergy publication-title: Allergy – volume: 121 start-page: 69 year: 2018 end-page: 76 article-title: Development of a tool predicting severity of allergic reaction during peanut challenge publication-title: Ann Allergy Asthma Immunol – volume: 5 start-page: 233 year: 2017 end-page: 243 article-title: Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps publication-title: Immun Inflamm Dis – volume: 127 start-page: 2210 year: 2017 end-page: 2218 article-title: Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients publication-title: Laryngoscope – volume: 71 start-page: 567 year: 2016 end-page: 570 article-title: Nasal and pharyngeal eosinophil peroxidase levels in adults with poorly controlled asthma correlate with sputum eosinophilia publication-title: Allergy – volume: 149 start-page: 1025 year: 2013 end-page: 1032 article-title: Relationship between the HLA‐B*1502 allele and carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta‐analysis publication-title: JAMA Dermatol – volume: 71 start-page: 1057 year: 2016 end-page: 1061 article-title: Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double‐blind placebo‐controlled clinical trial publication-title: Allergy – volume: 195 start-page: 1311 year: 2017 end-page: 1320 article-title: A severe asthma disease signature from gene expression profiling of peripheral blood from U‐BIOPRED cohorts publication-title: Am J Respir Crit Care Med – volume: 38 start-page: 90 year: 2012 end-page: 99 article-title: Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics publication-title: Exp Lung Res – volume: 137 start-page: 1138 year: 2016 end-page: 1142 article-title: Tryptase levels in children presenting with anaphylaxis: temporal trends and associated factors publication-title: J Allergy Clin Immunol – volume: 5 start-page: 990 year: 2017 end-page: 997 article-title: Urinary leukotriene E4 to determine aspirin intolerance in asthma: a systematic review and meta‐analysis publication-title: J Allergy Clin Immunol Pract – volume: 15 start-page: 262 year: 2017 article-title: Exhaled breath condensate metabolome clusters for endotype discovery in asthma publication-title: J Transl Med – volume: 28 start-page: 151 year: 2018 end-page: 164 article-title: Alergologica 2015: a national survey on allergic diseases in the adult Spanish population publication-title: J Investig Allergol Clin Immunol – volume: 70 start-page: 115 year: 2015 end-page: 120 article-title: External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma publication-title: Thorax – volume: 135 start-page: 877 year: 2015 end-page: 883 article-title: Biomarker‐based asthma phenotypes of corticosteroid response publication-title: J Allergy Clin Immunol – volume: 44 start-page: 212 year: 2014 end-page: 221 article-title: Frequent exacerbators–a distinct phenotype of severe asthma publication-title: Clin Exp Allergy – volume: 71 start-page: 1472 year: 2016 end-page: 1479 article-title: Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma publication-title: Allergy – volume: 43 start-page: 1217 year: 2013 end-page: 1225 article-title: Predicting steroid responsiveness in patients with asthma using exhaled breath profiling publication-title: Clin Exp Allergy – volume: 37 start-page: 35 year: 2016 end-page: 42 article-title: Biomarker assessment in chronic rhinitis and chronic rhinosinusitis: endothelin‐1, TARC/CCL17, neopterin, and alpha‐defensins publication-title: Allergy Asthma Proc – volume: 72 start-page: 473 year: 2017 end-page: 482 article-title: Airway and peripheral urokinase plasminogen activator receptor is elevated in asthma, and identifies a severe, nonatopic subset of patients publication-title: Allergy – volume: 47 start-page: 339 year: 2017 end-page: 350 article-title: The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions publication-title: Clin Exp Allergy – volume: 72 start-page: 1356 year: 2017 end-page: 1364 article-title: The skin barrier function gene SPINK5 is associated with challenge‐proven IgE‐mediated food allergy in infants publication-title: Allergy – volume: 22 start-page: 6784 year: 2016 end-page: 6802 article-title: Hypersensitivity reactions to non‐steroidal anti‐inflammatory drugs publication-title: Curr Pharm Des – volume: 43 start-page: 1027 year: 2013 end-page: 1037 article-title: In vitro drug causality assessment in Stevens‐Johnson syndrome ‐ alternatives for lymphocyte transformation test publication-title: Clin Exp Allergy – volume: 62 start-page: 47 year: 2007 end-page: 52 article-title: Relevance of the determination of serum‐specific IgE antibodies in the diagnosis of immediate beta‐lactam allergy publication-title: Allergy – volume: 7 start-page: 11949 year: 2017 article-title: Dermatophagoides pteronyssinus immunotherapy changes the T‐regulatory cell activity publication-title: Sci Rep – volume: 4 start-page: 665 year: 2016 end-page: 670 article-title: Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity publication-title: J Allergy Clin Immunol Pract – volume: 27 start-page: 276 year: 2016 end-page: 282 article-title: Differential response in allergen‐specific IgE, IgGs, and IgA levels for predicting outcome of oral immunotherapy publication-title: Pediatr Allergy Immunol – volume: 48 start-page: 1040 year: 2016 end-page: 1051 article-title: Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study publication-title: Eur Respir J – volume: 137 start-page: 75 year: 2016 end-page: 86 article-title: Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia publication-title: J Allergy Clin Immunol – volume: 18 start-page: 28 year: 2018 article-title: Food protein‐induced enterocolitis syndrome (FPIES): review of recent guidelines publication-title: Curr Allergy Asthma Rep – volume: 139 start-page: 1379 year: 2017 end-page: 1383 article-title: Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in severe asthma publication-title: J Allergy Clin Immunol – volume: 71 start-page: 1103 year: 2016 end-page: 1134 article-title: In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper publication-title: Allergy – volume: 73 start-page: 837 year: 2018 end-page: 850 article-title: Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications publication-title: Allergy – volume: 71 start-page: 1037 year: 2016 end-page: 1047 article-title: Sex hormones and systemic inflammation are modulators of the obese‐asthma phenotype publication-title: Allergy – volume: 137 start-page: 400 year: 2016 end-page: 411 article-title: Platelet activation markers overexpressed specifically in patients with aspirin‐exacerbated respiratory disease publication-title: J Allergy Clin Immunol – volume: 95 start-page: e3679 year: 2016 article-title: Hypersensitivity to fluoroquinolones: the expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone publication-title: Medicine (Baltimore) – year: 2018 article-title: Childhood asthma clusters reveal neutrophil‐predominant phenotype with distinct gene expression publication-title: Allergy – volume: 50 start-page: 1700800 year: 2017 article-title: Characterisation of asthma subgroups associated with circulating YKL‐40 levels publication-title: Eur Respir J – volume: 50 start-page: 1602298 year: 2017 article-title: Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma publication-title: Eur Respir J – volume: 51 start-page: 1701817 year: 2018 article-title: Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label publication-title: Eur Respir J – volume: 72 start-page: 671 year: 2017 end-page: 674 article-title: Pla a 2 and Pla a 3 reactivities identify plane tree‐allergic patients with respiratory symptoms or food allergy publication-title: Allergy – volume: 51 start-page: 1800324 year: 2018 article-title: What is the minimal clinically important difference for helium‐3 magnetic resonance imaging ventilation defects? publication-title: Eur Respir J – volume: 139 start-page: 882 year: 2017 end-page: 888 article-title: Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy publication-title: J Allergy Clin Immunol – volume: 3 start-page: 849 year: 2015 end-page: 858 article-title: Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study publication-title: Lancet Respir Med – volume: 47 start-page: 442 year: 2017 end-page: 456 article-title: Allergic asthma: an overview of metabolomic strategies leading to the identification of biomarkers in the field publication-title: Clin Exp Allergy – volume: 71 start-page: 258 year: 2016 end-page: 266 article-title: Low indoleamine 2,3‐dioxygenase activity in persistent food allergy in children publication-title: Allergy – volume: 59 start-page: 855 year: 2017 end-page: 860 article-title: Prognosis of infantile food protein‐induced enterocolitis syndrome in Japan publication-title: Pediatr Int – volume: 64 start-page: 242 year: 2009 end-page: 248 article-title: Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins publication-title: Allergy – volume: 176 start-page: 1062 year: 2007 end-page: 1071 article-title: A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma publication-title: Am J Respir Crit Care Med – volume: 72 start-page: 1156 year: 2017 end-page: 1173 article-title: Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper publication-title: Allergy – volume: 72 start-page: 1883 year: 2017 end-page: 1890 article-title: Changes in patient quality of life during oral immunotherapy for food allergy publication-title: Allergy – volume: 374 start-page: 484 year: 2016 end-page: 488 article-title: Aspirin‐exacerbated respiratory disease–new prime suspects publication-title: N Engl J Med – volume: 28 start-page: 487 year: 2017 end-page: 490 article-title: Prediction of cashew nut allergy in sensitized children publication-title: Pediatr Allergy Immunol – volume: 139 start-page: 1548 year: 2017 end-page: 1558 article-title: Mechanism of TH2/TH17‐predominant and neutrophilic TH2/TH17‐low subtypes of asthma publication-title: J Allergy Clin Immunol – volume: 133 start-page: 997 year: 2014 end-page: 1007 article-title: Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes publication-title: J Allergy Clin Immunol – volume: 33 start-page: 1605 year: 2017 end-page: 1613 article-title: The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies publication-title: Curr Med Res Opin – volume: 109 start-page: 1391 year: 2015 end-page: 1396 article-title: Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma publication-title: Respir Med – volume: 7 start-page: 301ra129 issue: 301 year: 2015 article-title: TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma publication-title: Sci Transl Med – volume: 125 start-page: 502 year: 2010 end-page: 505 article-title: Clavulanic acid can be the component in amoxicillin‐clavulanic acid responsible for immediate hypersensitivity reactions publication-title: J Allergy Clin Immunol – volume: 137 start-page: 1390 year: 2016 end-page: 1397 article-title: Gene expression profiling of asthma phenotypes demonstrates molecular signatures of atopy and asthma control publication-title: J Allergy Clin Immunol – volume: 72 start-page: 1202 year: 2017 end-page: 1211 article-title: Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness publication-title: Allergy – volume: 6 start-page: 36599 year: 2016 article-title: Exploration of the sphingolipid metabolite, sphingosine‐1‐phosphate and sphingosine, as novel biomarkers for aspirin‐exacerbated respiratory disease publication-title: Sci Rep – volume: 187 start-page: 804 year: 2013 end-page: 811 article-title: Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study publication-title: Am J Respir Crit Care Med – volume: 72 start-page: 1346 year: 2017 end-page: 1355 article-title: Natural evolution in patients with nonsteroidal anti‐inflammatory drug‐induced urticaria/angioedema publication-title: Allergy – volume: 45 start-page: 613 year: 2015 end-page: 623 article-title: Local and systemic effects of cat allergen nasal provocation publication-title: Clin Exp Allergy – volume: 72 start-page: 1753 year: 2017 end-page: 1760 article-title: Serum periostin relates to type‐2 inflammation and lung function in asthma: data from the large population‐based cohort Swedish GA(2)LEN publication-title: Allergy – volume: 137 start-page: 1449 year: 2016 end-page: 1456 article-title: Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers publication-title: J Allergy Clin Immunol – volume: 3 start-page: 290 year: 2015 end-page: 300 article-title: Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta‐analysis publication-title: Lancet Respir Med – volume: 48 start-page: 1147 year: 2018 end-page: 1154 article-title: IgE sensitization to food allergens and airborne allergens in relation to biomarkers of type 2 inflammation in asthma publication-title: Clin Exp Allergy – volume: 47 start-page: 1390 year: 2017 end-page: 1397 article-title: Invariant natural killer cells change after an oral allergy desensitization protocol for cow's milk publication-title: Clin Exp Allergy – volume: 73 start-page: 269 year: 2018 end-page: 283 article-title: Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview publication-title: Allergy – volume: 133 start-page: 1332 year: 2014 end-page: 1339 article-title: Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis publication-title: J Allergy Clin Immunol – ident: e_1_2_10_58_1 doi: 10.1111/all.12206 – ident: e_1_2_10_88_1 doi: 10.1016/j.jaci.2014.05.038 – ident: e_1_2_10_99_1 doi: 10.1080/03007995.2017.1347091 – ident: e_1_2_10_92_1 doi: 10.3109/01902148.2011.649823 – ident: e_1_2_10_47_1 doi: 10.1111/all.13117 – ident: e_1_2_10_20_1 doi: 10.1016/j.jaci.2009.02.012 – ident: e_1_2_10_116_1 doi: 10.1111/all.12820 – ident: e_1_2_10_9_1 doi: 10.1111/cea.12147 – ident: e_1_2_10_82_1 doi: 10.1016/j.jaci.2013.10.011 – ident: e_1_2_10_121_1 doi: 10.1111/all.13176 – ident: e_1_2_10_136_1 doi: 10.1111/ped.13305 – ident: e_1_2_10_127_1 doi: 10.1111/pai.12535 – ident: e_1_2_10_146_1 doi: 10.1111/cea.12797 – ident: e_1_2_10_128_1 doi: 10.1016/j.jaci.2016.07.030 – ident: e_1_2_10_77_1 doi: 10.1111/all.13181 – ident: e_1_2_10_120_1 doi: 10.1016/j.jaci.2015.09.001 – ident: e_1_2_10_102_1 doi: 10.1111/cea.13057 – ident: e_1_2_10_122_1 doi: 10.1111/all.13124 – ident: e_1_2_10_149_1 doi: 10.1038/srep36599 – ident: e_1_2_10_151_1 doi: 10.1111/all.13147 – ident: e_1_2_10_2_1 doi: 10.1111/all.13496 – ident: e_1_2_10_96_1 doi: 10.1164/rccm.201208-1414OC – ident: e_1_2_10_60_1 doi: 10.1126/scitranslmed.aab3142 – ident: e_1_2_10_75_1 doi: 10.1016/j.jaci.2016.11.041 – ident: e_1_2_10_14_1 doi: 10.1016/j.anai.2017.01.018 – ident: e_1_2_10_81_1 doi: 10.1002/ppul.23331 – ident: e_1_2_10_45_1 doi: 10.1016/j.rmed.2015.09.016 – ident: e_1_2_10_64_1 doi: 10.1111/all.13235 – ident: e_1_2_10_55_1 doi: 10.1016/j.jaci.2013.12.1091 – ident: e_1_2_10_101_1 doi: 10.1016/j.jaci.2016.09.028 – ident: e_1_2_10_22_1 doi: 10.1111/cea.12434 – ident: e_1_2_10_13_1 doi: 10.1111/cea.13192 – ident: e_1_2_10_73_1 doi: 10.1183/13993003.00336-2016 – ident: e_1_2_10_42_1 doi: 10.1111/all.13205 – ident: e_1_2_10_18_1 doi: 10.1111/all.12889 – ident: e_1_2_10_62_1 doi: 10.1183/13993003.01817-2017 – ident: e_1_2_10_87_1 doi: 10.1183/13993003.02298-2016 – ident: e_1_2_10_131_1 doi: 10.1002/mnfr.201700669 – ident: e_1_2_10_93_1 doi: 10.1183/13993003.00324-2018 – ident: e_1_2_10_140_1 doi: 10.18176/jiaci.0264 – ident: e_1_2_10_16_1 doi: 10.1016/j.clim.2017.09.008 – ident: e_1_2_10_50_1 doi: 10.1111/all.13046 – ident: e_1_2_10_67_1 doi: 10.1186/s12967-017-1365-7 – ident: e_1_2_10_100_1 doi: 10.1056/NEJMoa1804092 – ident: e_1_2_10_59_1 doi: 10.1111/all.12817 – ident: e_1_2_10_163_1 doi: 10.1038/clpt.2011.355 – ident: e_1_2_10_34_1 doi: 10.1038/nm.2678 – ident: e_1_2_10_114_1 doi: 10.18632/oncotarget.13374 – ident: e_1_2_10_8_1 doi: 10.1183/09031936.05.00029705 – ident: e_1_2_10_115_1 doi: 10.1111/all.12785 – ident: e_1_2_10_86_1 doi: 10.1016/j.jaci.2016.12.963 – ident: e_1_2_10_111_1 doi: 10.1002/ppul.23371 – ident: e_1_2_10_17_1 doi: 10.1111/all.13138 – ident: e_1_2_10_35_1 doi: 10.1164/rccm.200701-085OC – ident: e_1_2_10_33_1 doi: 10.1002/alr.21598 – ident: e_1_2_10_154_1 doi: 10.1111/j.1398-9995.2008.01713.x – ident: e_1_2_10_28_1 doi: 10.1111/all.13340 – ident: e_1_2_10_23_1 doi: 10.1038/s41598-017-12261-2 – ident: e_1_2_10_3_1 doi: 10.1111/all.13399 – ident: e_1_2_10_108_1 doi: 10.1136/thx.2010.135574 – ident: e_1_2_10_164_1 doi: 10.1056/NEJMoa0706135 – ident: e_1_2_10_94_1 doi: 10.1164/rccm.201709-1948OC – ident: e_1_2_10_38_1 doi: 10.1183/13993003.02383-2016 – ident: e_1_2_10_46_1 doi: 10.1016/j.jaci.2013.03.044 – ident: e_1_2_10_134_1 doi: 10.1007/s11882-018-0767-9 – ident: e_1_2_10_105_1 doi: 10.1016/j.rmed.2007.01.011 – ident: e_1_2_10_11_1 doi: 10.1016/j.jaci.2013.08.026 – ident: e_1_2_10_117_1 doi: 10.1111/cea.12794 – ident: e_1_2_10_43_1 doi: 10.1016/j.jaci.2016.09.031 – ident: e_1_2_10_25_1 doi: 10.1016/j.jaci.2016.05.041 – volume: 9 start-page: Cd011440 year: 2016 ident: e_1_2_10_110_1 article-title: Exhaled nitric oxide levels to guide treatment for adults with asthma publication-title: Cochrane Database Syst Rev – ident: e_1_2_10_65_1 doi: 10.1111/all.13049 – ident: e_1_2_10_138_1 doi: 10.1016/j.anai.2018.04.020 – ident: e_1_2_10_90_1 doi: 10.1111/cea.12179 – ident: e_1_2_10_97_1 doi: 10.1183/13993003.02523-2017 – ident: e_1_2_10_5_1 doi: 10.1016/j.chest.2016.10.008 – ident: e_1_2_10_51_1 doi: 10.1186/s12890-016-0230-4 – ident: e_1_2_10_129_1 doi: 10.1016/j.jaci.2017.03.028 – ident: e_1_2_10_158_1 doi: 10.1016/j.jaci.2009.11.032 – ident: e_1_2_10_162_1 doi: 10.1111/cea.12145 – ident: e_1_2_10_24_1 doi: 10.1111/all.12644 – ident: e_1_2_10_61_1 doi: 10.1016/j.jaci.2016.08.032 – ident: e_1_2_10_139_1 doi: 10.1111/all.13121 – ident: e_1_2_10_98_1 doi: 10.1016/S2213-2600(16)30031-5 – ident: e_1_2_10_155_1 doi: 10.1016/j.jaci.2012.11.017 – ident: e_1_2_10_71_1 doi: 10.1016/S2213-2600(15)00367-7 – ident: e_1_2_10_107_1 doi: 10.1016/S0140-6736(02)11679-5 – ident: e_1_2_10_72_1 doi: 10.1183/13993003.02536-2017 – ident: e_1_2_10_124_1 doi: 10.1111/pai.12510 – ident: e_1_2_10_112_1 doi: 10.1038/nri.2016.111 – ident: e_1_2_10_37_1 doi: 10.1136/thx.2008.103069 – ident: e_1_2_10_157_1 doi: 10.1111/j.1365-2222.2004.02110.x – ident: e_1_2_10_79_1 doi: 10.1016/j.jaci.2013.03.003 – ident: e_1_2_10_52_1 doi: 10.1136/thoraxjnl-2014-205634 – ident: e_1_2_10_30_1 doi: 10.1111/all.13136 – ident: e_1_2_10_161_1 doi: 10.1111/all.13236 – ident: e_1_2_10_148_1 doi: 10.1016/j.jaci.2015.05.041 – ident: e_1_2_10_119_1 doi: 10.1111/cea.12735 – ident: e_1_2_10_49_1 doi: 10.1038/s41598-017-09120-5 – ident: e_1_2_10_66_1 doi: 10.1111/all.13596 – ident: e_1_2_10_150_1 doi: 10.1016/j.jaci.2017.01.022 – ident: e_1_2_10_104_1 doi: 10.1111/all.12922 – ident: e_1_2_10_143_1 doi: 10.1111/all.13075 – ident: e_1_2_10_126_1 doi: 10.1111/apa.13550 – ident: e_1_2_10_91_1 doi: 10.1111/cea.12965 – ident: e_1_2_10_57_1 doi: 10.1016/j.jaci.2016.02.018 – ident: e_1_2_10_109_1 doi: 10.1016/S2213-2600(17)30424-1 – ident: e_1_2_10_113_1 doi: 10.1111/all.13132 – ident: e_1_2_10_123_1 doi: 10.1111/all.13211 – ident: e_1_2_10_130_1 doi: 10.1111/cea.12901 – ident: e_1_2_10_159_1 doi: 10.1016/j.anai.2013.08.012 – ident: e_1_2_10_166_1 doi: 10.1038/clpt.2013.103 – ident: e_1_2_10_84_1 doi: 10.1016/j.jaip.2017.01.026 – ident: e_1_2_10_156_1 doi: 10.1111/all.12886 – ident: e_1_2_10_118_1 doi: 10.1111/pai.12726 – ident: e_1_2_10_32_1 doi: 10.1001/jamaoto.2016.0927 – ident: e_1_2_10_69_1 doi: 10.1111/all.13143 – ident: e_1_2_10_76_1 doi: 10.1080/02770903.2018.1455855 – ident: e_1_2_10_29_1 doi: 10.1097/01.mlg.0000147917.43615.c0 – ident: e_1_2_10_39_1 doi: 10.1164/rccm.201604-0866OC – ident: e_1_2_10_78_1 doi: 10.1016/j.jaci.2013.04.050 – ident: e_1_2_10_26_1 doi: 10.1016/j.jaci.2015.12.1324 – ident: e_1_2_10_40_1 doi: 10.1016/j.jaci.2015.09.058 – ident: e_1_2_10_63_1 doi: 10.1111/all.13254 – ident: e_1_2_10_74_1 doi: 10.1016/j.jaci.2015.07.037 – ident: e_1_2_10_160_1 doi: 10.1097/MD.0000000000003679 – ident: e_1_2_10_137_1 doi: 10.1111/cea.13165 – ident: e_1_2_10_41_1 doi: 10.1111/all.13439 – ident: e_1_2_10_70_1 doi: 10.1111/pai.12457 – ident: e_1_2_10_48_1 doi: 10.1164/rccm.201504-0760OC – ident: e_1_2_10_83_1 doi: 10.1016/j.jaci.2015.05.037 – ident: e_1_2_10_103_1 doi: 10.1111/resp.12602 – ident: e_1_2_10_12_1 doi: 10.1067/mai.2001.118891 – ident: e_1_2_10_89_1 doi: 10.1164/rccm.200905-0695OC – ident: e_1_2_10_15_1 doi: 10.2500/aap.2016.37.3899 – ident: e_1_2_10_106_1 doi: 10.1016/j.jaci.2014.10.026 – ident: e_1_2_10_145_1 doi: 10.1016/j.jaip.2016.11.004 – ident: e_1_2_10_56_1 doi: 10.1183/09031936.00024313 – ident: e_1_2_10_132_1 doi: 10.1053/j.gastro.2017.05.066 – ident: e_1_2_10_4_1 doi: 10.1016/j.alit.2016.04.011 – ident: e_1_2_10_165_1 doi: 10.1001/jamadermatol.2013.4114 – ident: e_1_2_10_27_1 doi: 10.1002/iid3.161 – ident: e_1_2_10_68_1 doi: 10.1016/j.jaci.2015.05.022 – ident: e_1_2_10_147_1 doi: 10.1016/j.prostaglandins.2015.07.001 – ident: e_1_2_10_44_1 doi: 10.1016/S2213-2600(15)00050-8 – ident: e_1_2_10_7_1 doi: 10.1111/cea.12902 – ident: e_1_2_10_21_1 doi: 10.1016/j.ijporl.2015.12.001 – ident: e_1_2_10_80_1 doi: 10.1183/13993003.00800-2017 – ident: e_1_2_10_10_1 doi: 10.1111/all.12573 – ident: e_1_2_10_95_1 doi: 10.1111/all.13302 – ident: e_1_2_10_142_1 doi: 10.1056/NEJMcibr1514013 – ident: e_1_2_10_6_1 doi: 10.1111/all.13563 – ident: e_1_2_10_152_1 doi: 10.1111/all.12142 – ident: e_1_2_10_153_1 doi: 10.1111/j.1398-9995.2006.01268.x – ident: e_1_2_10_31_1 doi: 10.1002/lary.26555 – ident: e_1_2_10_125_1 doi: 10.1111/cea.12975 – ident: e_1_2_10_36_1 doi: 10.1056/NEJMoa0808991 – ident: e_1_2_10_135_1 doi: 10.1159/000448755 – ident: e_1_2_10_85_1 doi: 10.1111/pai.12827 – ident: e_1_2_10_133_1 doi: 10.1097/MPG.0000000000001553 – ident: e_1_2_10_19_1 doi: 10.1111/all.13350 – ident: e_1_2_10_53_1 doi: 10.1111/all.12891 – ident: e_1_2_10_141_1 doi: 10.2174/1381612822666160928142814 – ident: e_1_2_10_144_1 doi: 10.1016/j.jaip.2016.03.004 – ident: e_1_2_10_54_1 doi: 10.1183/13993003.02135-2016 |
| SSID | ssj0007290 |
| Score | 2.5414276 |
| SecondaryResourceType | review_article |
| Snippet | The potential of precision medicine in allergy and asthma has only started to be explored. A significant clarification in the pathophysiology of rhinitis,... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2290 |
| SubjectTerms | Allergic diseases Asthma Biomarkers chronic rhinosinusitis Drug delivery Drug discovery drug hypersensitivity Food allergies food allergy Immunoglobulin E Leukocytes (eosinophilic) Pathophysiology Phenotypes Precision medicine Respiratory tract diseases Rhinitis Rhinosinusitis Sinusitis |
| Title | Recent developments and highlights in biomarkers in allergic diseases and asthma |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.13628 https://www.ncbi.nlm.nih.gov/pubmed/30289997 https://www.proquest.com/docview/2161031256 https://www.proquest.com/docview/2116849891 |
| Volume | 73 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB4WD-LF92N9UcWDly59JG2DJ_HBIioiCh6EkiYpimuV7e7FX-9M-lifIJ7a0gmZNpnkS2bmC8CeYCLPKe1DV7tV3HNlzpUbiiTPhfHzwFi2z8uof8vO7vhdBw6aXJiKH6LdcCPLsOM1GbjMyg9GLgcDitEKKNEXr8Sbf3w9oY6K6_0VxA8uQ6uuWYUoiqct-Xku-gYwP-NVO-GczsF9o2oVZ_LUG4-ynnr7wuL4z2-Zh9kaiDqHVc9ZgI4pFmH6ona1L8EVAkqckBw9iSoqHVlohwiOB7SkL53HwqH0fYrwGdonOphliGOpU_t9qhKyHD08y2W4PT25Oeq79fELrmK4jnG5YjriGaqVC65VzI1OLOIwMTEYK8MphSBATKEDJrkQMtKC-V4esizTMglXYKp4KcwaOIE2gnmhjIwIGWIe6RsvUUwlsQwyj5su7DcNkaqam5yOyBikzRoF9U_tH-rCbiv6WhFy_CS02bRmWttkmQYIbnEIQ4zXhZ32NVoTuUhkYV7GJONHCROJ8LuwWvWCtpaQnLJCxKisbcvfq08Pz8_tzfrfRTdgBrFYUkXKbMLUaDg2W4h3Rtm27djvqNL5BA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIhUuLbS0XVggoB56SZWHndgSlxVitbTZCqGt1EsVObYjUENa7ePSX8-M89iWh4S4JcpYmcQe-_M8PgMcSSbLkso-TOOt4oGvSq79WIqylDYsI-vYPs-TyQU7veSXG_Chq4Vp-CF6hxtZhpuvycDJIX3PylVVUZJWJB7BYxefI0j0dU0elbYeFkQQPkO7bnmFKI-nb_pwNfoNYj5ErG7JGe_AVadsk2lyfbJaFif67hcex__9mmew3WJRb9QMnuewYetd2Jq20fY9-IKYEtckz6wTixaeqo1HHMcV7eoX3vfaowp-SvKZuzs6m2WO06nXhn6aFmqx_PZDvYCL8afZx4nfnsDga4ZbGZ9rZhJeoFql5Ean3BrhQIdNicRYW05VBBHCChMxxaVUiZEsDMqYFYVRIt6HzfqmtofgRcZKFsQqsTJmCHtUaAOhmRapioqA2wEcdz2R65aenE7JqPJum4L65-4PDeB9L3rbcHL8SWjYdWfemuUijxDf4iyGMG8A7_rHaFAUJVG1vVmRTJgIJoUMB3DQDIP-LTHFZaVMUVnXmX9_fT7KMnfx8t9F38KTyWya5dnn87NX8BShmWgSZ4awuZyv7GuEP8vijRvlPwFCtf0i |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT90wEB5RkFAvZSm0rwWaVj30EpTFTmxxQsAThQdCCCQOSJHjRUW8BvSWC7--M85C2STELVHGyiT2eD57Zj4D_JRMOkdlH6bereJRqBzXYSqFc9LGLrGe7fM42z9nBxf8Yga22lqYmh-i23Ajy_DzNRn4rXH_GbkaDilHKxHvYI5l6CYJEZ3ec0flzQYLAoiQoVk3tEKUxtM1feiMniDMh4DVe5z-Aly2utaJJteb00m5qe8e0Ti-8WMW4UODRIPteugswYytlmH-qIm1f4QTRJTokQJzn1Y0DlRlAmI4HtKafhxcVQHV71OKz8jf0cksI5xMgybwU7dQ48mfv2oFzvt7Zzv7YXP-QqgZLmRCrpnJeIlqOcmNzrk1wkMOmxOFsbacaggSBBUmYYpLqTIjWRy5lJWlUSJdhdnqprKfIUiMlSxKVWZlyhD0qNhGQjMtcpWUEbc9-NV2RKEbcnI6I2NYtIsU1L_wf6gHPzrR25qR4zmhtbY3i8Yox0WC6BbnMAR5PfjePUZzohiJquzNlGTiTDApZNyDT_Uo6N6SUlRWyhyV9X358uuL7cHAX3x5veg3mD_Z7ReD38eHX-E94jJRZ82swexkNLXriH0m5YYf4_8ATKn70Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+developments+and+highlights+in+biomarkers+in+allergic+diseases+and+asthma&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Eguiluz-Gracia%2C+Ibon&rft.au=Tay%2C+Tunn+Ren&rft.au=Hew%2C+Mark&rft.au=Escribese%2C+Maria+M&rft.date=2018-12-01&rft.issn=1398-9995&rft.eissn=1398-9995&rft.volume=73&rft.issue=12&rft.spage=2290&rft_id=info:doi/10.1111%2Fall.13628&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |